 |
 |

Human Papillomavirus Antibody and Risk of Prostate Cancer
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Human papillomavirus type 16 (HPV 16) is the HPV type most frequently detected in human cancers and is associated with an increased risk of cervical and lower anogenital tract tumors. Some researchers have speculated that HPV infection may play a role in prostate cancer, a common malignancy among men, based on an association of this cancer with sexual activities.1 However, studies of HPV 16 DNA in prostate cancer tissues have shown inconsistent results.2-3
Methods
The association of prostate cancer risk with the presence of HPV 16 antibody was examined in a nested case-control study within the Child Health and Development Study cohort, which enrolled members of the Kaiser Foundation Health Plan residing in the Oakland, Calif, area between 1959 and 1966.4 Cancer cases were identified from more than 13,000 men in this cohort by linkage with the California Cancer Registry through October 1993 (estimated to have been 97% . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Sexually Transmitted Infections and Prostate Cancer among Men in the U.S. Military
Dennis et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2665-2671.
ABSTRACT
| FULL TEXT
Serologic Evidence of Human Papillomavirus 16 and 18 Infections and Risk of Prostate Cancer
Rosenblatt et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:763-768.
ABSTRACT
| FULL TEXT
|